Nerve sheath myxoma: A clinicopathologic and immunohistochemical analysis of 57 morphologically distinctive, S-100 protein- and GFAP-positive, myxoid peripheral nerve sheath tumors with a predilection for the extremities and a high local recurrence rate

American Journal of Surgical Pathology

Volumn 29, Issue 12, 2005, Pages 1615-1624

  Fetsch, John F ^a   Laskin, William B ^b   Miettinen, Markku ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Digital mucous cyst; Finger; Ganglion cyst; Immunohistochemistry; Nerve sheath myxoma; Neurofibroma; Neurothekeoma; Perineurial cell; Peripheral nerve sheath tumor; Plexiform; Schwannoma; Soft tissue tumor; Superficial acral fibromyxoma

Indexed keywords

CD34 ANTIGEN; CD57 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S 100;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL SHAPE; CELL ULTRASTRUCTURE; CLINICAL FEATURE; CYTOPLASM; DERMIS; FEMALE; FIBROBLAST; FOLLOW UP; GANGLION CYST; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MYXOMA; NERVE SHEATH TUMOR; NEURILEMOMA; ONSET AGE; SCHOOL CHILD; SCHWANN CELL; SUBCUTANEOUS TISSUE; TUMOR RECURRENCE; CHILD; COMPARATIVE STUDY; LIMB; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; CHILD; EXTREMITIES; FEMALE; FOLLOW-UP STUDIES; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYXOMA; NEOPLASM RECURRENCE, LOCAL; NERVE SHEATH NEOPLASMS; RETROSPECTIVE STUDIES; S100 PROTEINS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 33644811318     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000173025.87476.a4     Document Type: Article

References (33)

1. Allen PW. Myxoid tumors of soft tissues. Pathol Annu. 1980;15:133-192.
2. Allen PW, Dymock RB, MacCormac LB. Superficial angiomyxomas with and without epithelial components: report of 30 tumors in 28 patients. Am J Surg Pathol. 1988;12:519-530.
3. Angervall L, Kindblom L-G, Haglid K. Dermal nerve sheath myxoma: a light and electron microscopic, histochemical and immunohistochemical study. Cancer. 1984;53:1752-1759.
4. Argenyi ZB, LeBoit PE, Santa Cruz D, et al. Nerve sheath myxoma (neurothekeoma) of the skin: light microscopic and immunohistochemical reappraisal of the cellular variant. J Cutan Pathol. 1993;20:294-303.
5. Barnhill RL, Mihm MC Jr. Cellular neurothekeoma: a distinctive variant of neurothekeoma mimicking nevomelanocytic tumors. Am J Surg Pathol. 1990;14:113-120.
6. Barnhill RL, Dickersin GR, Nickeleit V, et al. Studies on the cellular origin of neurothekeoma: clinical, light microscopic, immunohistochemical, and ultrastructural observations. J Am Acad Dermatol. 1991;25:80-88.
7. Bhaskar AR, Kanvinde R. Neurothekeoma of the hand. J Hand Surg [Br]. 1999;24:631-633.
8. Blumberg AK, Kay S, Adelaar RS. Nerve sheath myxoma of digital nerve. Cancer. 1989;63:1215-1218.
9. Calonje E, Wilson-Jones E, Smith NP, et al. Cellular 'neurothekeoma': an epithelioid variant of pilar leiomyoma? Morphological and immunohistochemical analysis of a series. Histopathology. 1992;20:397-404.
10. Calonje E, Guerin D, McCormick D, et al. Superficial angiomyxoma: clinicopathologic analysis of a series of distinctive but poorly recognized cutaneous tumors with tendency for recurrence. Am J Surg Pathol. 1999;23:910-917.
11. Carney JA, Headington JT, Su WPD. Cutaneous myxomas: a major component of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Arch Dermatol. 1986;122:790-798.
12. Carney JA. The Carney complex (Myxomas, spotty pigmentation, endocrine overactivity, and schwannomas). Dermatol Clin. 1995;13:19-26.
13. Connolly M, Hickey JR, Intzedy L, et al. Subungual neurothekeoma. J Am Acad Dermatol. 2005;52:159-162.
14. Fetsch JF, Laskin WB, Tavassoli FA. Superficial angiomyxoma (cutaneous myxoma): a clinicopathologic study of 17 cases arising in the genital region. Int J Gynecol Pathol. 1997;16:325-334.
15. Fetsch JF, Miettinen M. Sclerosing perineurioma: a clinicopathologic study of 19 cases of a distinctive soft tissue lesion with a predilection for the fingers and palms of young adults. Am J Surg Pathol. 1997;21:1433-1442.
16. Fetsch JF, Laskin WB, Miettinen M. Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Hum Pathol. 2001;32:704-714.
17. Fullen DR, Lowe L, Su LD. Antibody to S100a6 protein is a sensitive immunohistochemical marker for neurothekeoma. J Cutan Pathol. 2003;30:118-122.
18. Gallager RL, Helwig EB. Neurothekeoma: a benign cutaneous tumor of neural origin. Am J Clin Pathol. 1980;74:759-764.
19. Graadt van Roggen JF, McMenamin ME, Belchis DA, et al. Reticular perineurioma: a distinctive variant of soft tissue perineurioma. Am J Surg Pathol. 2001;25:485-493.
20. Harkin JC, Reed RJ. Solitary benign nerve sheath tumors. In: Firminger HI, ed. Atlas of Tumor Pathology, Tumors of the Peripheral Nervous System, 2nd series. Washington, DC: Armed Forces Institute of Pathology, 1969:60-64.
21. Holden CA, Wilson-Jones E, MacDonald DM. Cutaneous lobular neuromyxoma. Br J Dermatol. 1982;106:211-215.
22. Husain S, Silvers DN, Halperin AJ, et al. Histologic spectrum of neurothekeoma and the value of immunoperoxidase staing for S-100 protein in distinguishing it from melanoma. Am J Dermatopathol. 1994;16:496-503.
23. King DT, Barr RJ. Bizarre cutaneous neurofibromas. J Cutan Pathol. 1980;7:21-31.
24. Laskin WB, Fetsch JF, Miettinen M. The 'neurothekeoma ': immunohistochemical analysis distinguishes the true nerve sheath myxoma from its mimics. Hum Pathol. 2000;31:1230-1241.
25. MacDonald DM, Wilson-Jones E. Pacinian neurofibroma. Histopathology. 1977;1:247-255.
26. Michal M. Extraneural retiform perineuriomas: a report of four cases. Pathol Res Pract. 1999;195:759-763.
27. Page RN, King R, Mihm MC Jr, et al. Microphthalmia transcription factor and NKI/C3 expression in cellular neurothekeoma. Mod Pathol. 2004;17:230-234.
28. Pulitzer DR, Reed RJ. Nerve-sheath myxoma (perineurial myxoma). Am J Dermatopathol. 1985;7:409-421.
29. Scheithauer BW, Woodruff JM, Erlandson RA. Miscellaneous benign neurogenic tumors. In: Rosai J, Sobin LH, eds. Atlas of Tumor Pathology, Tumors of the Peripheral Nervous System, 3rd series. Washington, DC: Armed Forces Institute of Pathology 1999:219-282.
30. Ushigome S, Takakuwa T, Hyūga M, et al. Perineurial cell tumor and the significance of the perineurial cells in neurofibroma. Acta Pathol Jpn. 1986;36:973-987.
31. Webb JN. The histogenesis of nerve sheath myxoma: report of a case with electron microscopy. J Pathol. 1979;127:35-37.
32. Yamamoto H, Kawana T. Oral nerve sheath myxoma: report of a case with findings of ultrastructural and immunohistochemical studies. Acta Pathol Jpn. 1988;38:121-127.
33. Zelger BG, Steiner H, Kutzner H, et al. Cellular 'neurothekeoma': an epithelioid variant of dermatofibroma? Histopathology. 1998;32:414-422.